NOVO NORDISK A/S

NOVO B
Real-time Estimate Cboe Europe - 10:59 2022-12-07 am EST
888.90 DKK -0.68%

Turn to zoom
Prev.895.00000000
Open886.70000000
High896.00000000
Low886.60000000
Volume1 255 020
Latest news
6h ago
2d ago
2d ago
2d ago
Chart NOVO NORDISK A/S
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance901901897
Spread/Res.-1,3%-1,3%-0,90%
Spread/Supp.5,6%11%19%
Support842801749
Financials
Sales 2022 176 B 24 856 M 24 856 M
Net income 2022 55 184 M 7 803 M 7 803 M
Net Debt 2022 5 421 M 767 M 767 M
P/E ratio 2022 36,7x
Yield 2022 1,32%
Capitalization 2 022 B 286 B 286 B
EV / Sales 2022 11,5x
EV / Sales 2023 10,0x
Nbr of Employees 52 696
Free-Float 75,0%
Company
Novo Nordisk A/S specializes in the design, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- products for treating diabetes and obesity (86.4%);
- hemophilia treatment products (7.3%): mainly injections of protein;
- growth hormones (5.
Sector :
Other Pharmaceuticals
Calendar :
2023-02-01 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 895,00 DKK
Average target price 878,75 DKK
Spread / Average Target -1,82%